LncSIK1 enhanced the sensitivity of AML cells to retinoic acid by the E2F1/autophagy pathway. Issue 3 (29th January 2022)
- Record Type:
- Journal Article
- Title:
- LncSIK1 enhanced the sensitivity of AML cells to retinoic acid by the E2F1/autophagy pathway. Issue 3 (29th January 2022)
- Main Title:
- LncSIK1 enhanced the sensitivity of AML cells to retinoic acid by the E2F1/autophagy pathway
- Authors:
- Wang, Ke
Liu, Jun‐da
Deng, Ge
Ou, Zi‐yao
Li, Shu‐fang
Xu, Xiao‐ling
Zhang, Mei‐Ju
Peng, Xiao‐Qing
Chen, Fei‐hu - Abstract:
- Abstract: Objectives: This study aimed to investigate the biological impacts and possible mechanisms of a novel lncRNA, LncSIK1, in AML progression and retinoic acid‐regulated AML cell development. Materials and Methods: The expression pattern of LncSIK1 was evaluated by qPCR and fluorescence in situ hybridization. CCK‐8 assay, immunofluorescence, Wright‐Giemsa staining, flow cytometry and Western blotting were performed to assess cell proliferation and differentiation. Bioluminescence imaging and H&E staining were used to detect AML progression in vivo . RNA or chromatin immunoprecipitation assays were conducted to measure the interaction of E2F1 and LncSIK1 or the LC3 and DRAM promoters. Autophagy was measured by transmission electron microscopy and Western blotting. Results: LncSIK1 was silenced in bone marrow mononuclear cells from AML patients compared with those from healthy donors. LncSIK1 strengthened the effect of retinoic acid in inducing cell differentiation and inhibiting cell proliferation in AML cells. Moreover, the silencing of LncSIK1 was critical to maintaining AML leukaemogenesis, as LncSIK1 enhancement retarded AML progression in vivo . Mechanistically, in NB4 cells, LncSIK1 recruited the E2F1 protein to the promoters of LC3 and DRAM and induced autophagy‐dependent degradation of the oncoprotein PML‐RARa. However, LncSIK1 blocked E2F1 expression and the E2F1‐mediated transcription of LC3 and DRAM, thereby relieving aggressive autophagy in Molm13 cells.Abstract: Objectives: This study aimed to investigate the biological impacts and possible mechanisms of a novel lncRNA, LncSIK1, in AML progression and retinoic acid‐regulated AML cell development. Materials and Methods: The expression pattern of LncSIK1 was evaluated by qPCR and fluorescence in situ hybridization. CCK‐8 assay, immunofluorescence, Wright‐Giemsa staining, flow cytometry and Western blotting were performed to assess cell proliferation and differentiation. Bioluminescence imaging and H&E staining were used to detect AML progression in vivo . RNA or chromatin immunoprecipitation assays were conducted to measure the interaction of E2F1 and LncSIK1 or the LC3 and DRAM promoters. Autophagy was measured by transmission electron microscopy and Western blotting. Results: LncSIK1 was silenced in bone marrow mononuclear cells from AML patients compared with those from healthy donors. LncSIK1 strengthened the effect of retinoic acid in inducing cell differentiation and inhibiting cell proliferation in AML cells. Moreover, the silencing of LncSIK1 was critical to maintaining AML leukaemogenesis, as LncSIK1 enhancement retarded AML progression in vivo . Mechanistically, in NB4 cells, LncSIK1 recruited the E2F1 protein to the promoters of LC3 and DRAM and induced autophagy‐dependent degradation of the oncoprotein PML‐RARa. However, LncSIK1 blocked E2F1 expression and the E2F1‐mediated transcription of LC3 and DRAM, thereby relieving aggressive autophagy in Molm13 cells. Conclusions: Taken together, these data indicated that LncSIK1 was an important regulator of AML development through regulating the E2F1/autophagy signalling pathway. Abstract : The hypothetical regulatory network of LncSIK1 in NB4 and Molm13 cells. LncSIK1 exerted its significant positive effect on the sensitivity of AML cells to retinoic acid. LncSIK1 enhancement retarded AML progression in vitro and in vivo . The E2F1/autophagy axis played an important role in LncSIK1‐regulated AML development. … (more)
- Is Part Of:
- Cell proliferation. Volume 55:Issue 3(2022)
- Journal:
- Cell proliferation
- Issue:
- Volume 55:Issue 3(2022)
- Issue Display:
- Volume 55, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 55
- Issue:
- 3
- Issue Sort Value:
- 2022-0055-0003-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-01-29
- Subjects:
- acute myeloid leukaemia -- autophagy -- E2F1 -- LncSIK1 -- retinoic acid
Cell proliferation -- Periodicals
571.84 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2184 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cpr.13185 ↗
- Languages:
- English
- ISSNs:
- 0960-7722
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3097.854000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21017.xml